REVVITY, INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price (Deprecated 2012-01-31)
REVVITY, INC (RVTY) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) of $22.34 as of 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice · last filed 2012-11-06
- 2012-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) $22.34.
- 2012-07-01: Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) $22.26.
- 2012-04-01: Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) $22.21.
- 2012-01-01: Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) $30.29.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) |
|---|---|
| 2012-09-30 | $22.34 10-Q · filed 2012-11-06 |
| 2012-07-01 | $22.26 10-Q · filed 2012-08-07 |
| 2012-04-01 | $22.21 10-Q · filed 2012-05-08 |
| 2012-01-01 | $30.29 10-K · filed 2012-02-28 |
| 2011-10-02 | $30.40 10-Q · filed 2011-11-04 |
| 2011-07-03 | $30.64 10-Q · filed 2011-08-10 |
| 2011-01-02 | $25.19 10-K · filed 2012-02-28 |
| 2010-01-03 | $28.50 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |